Alnylam Pharmaceuticals Inc
ALNY
$224.47+0.29%
End of day · as of Oct 15, 2026, 2:00 AM ET
Mkt cap
$40.46B
EV/Sales
10.4
P/E ratio
37.5
FY2025 Revenue
$3.71B
EPS (TTM)
$5.99
Gross Margin (FY2025)
81.77%
Profit Margin (FY2025)
8.45%
Beta
0.27
Div yield
N/A
Sector
Healthcare
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Latest reported ALNY revenue for 2025-12-31 was $3.71B. Net income was $313.7M. Revenue was up 65.2% from 2024-12-31 to 2025-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 37.5.
Use this ALNY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ALNY income, balance, and cash tables.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company in the Healthcare sector.
Latest cached Alnylam Pharmaceuticals Inc (ALNY) revenue for Dec 31, 2025 was $3.71B. Net income was $313.7M. Statements: https://lician.com/financials/alny
Alnylam Pharmaceuticals Inc (ALNY) trailing P/E is 37.5 on the latest cached fundamentals snapshot.
Alnylam Pharmaceuticals Inc (ALNY) market capitalization is $40.46B on the latest cached snapshot.
Alnylam Pharmaceuticals Inc (ALNY) cached previous close $223.82; day range $224.42 – $224.49; volume 1,094,324. Session quote: https://lician.com/quote/alny
Alnylam Pharmaceuticals Inc (ALNY) latest cached earnings event is "ALNY earnings" on Jul 30, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ALNY filing is 8-K · Jul 30, 2026. Filings: https://lician.com/sec/alny